Ophthalmology

Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human oversight and control, and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incompl…

Authorship changes after submission require a written request signed by all authors. 模型摘要

The journal adheres to the Uniform Requirements set by the International Committee of Medical Journal Editors (https://www.icmje.org/) for authorship. Each author must meet criteria for Authorship. The ICMJE recommends that authorship be based on the following 4 criteria:Substantial contributions to conception or design of the work; or the acquisition, analysis, or interpretation of data for the w…

Authors must disclose the use of generative AI and AI-assisted technologies in the writing process by adding a statement at the end of their manuscript in the core manuscript file, before the References list. The statement should be placed in a new section entitled ‘Declaration of Generative AI and AI-assisted technologies in the writing process’. Statement: During the preparation of this work the…

To promote transparency and opportunities for further research, authors of work published in Ophthalmology are encouraged to provide access to relevant datasets in compliance with contemporary reporting standards. Authors may use domain-specific public archives (for example, ClinicalTrials.gov, GenBank, Protein Data Bank), or generic databases (for example, Dataverse, Dryad, Mendeley, or the Open …

Authors must confirm compliance with Elsevier Guidelines for Ethics in Publishing. 模型摘要

Before completing the submission, authors must confirm that their submission conforms with the Elsevier Guidelines for Ethics in Publishing, see https://www.elsevier.com/publishingethics and https://www.elsevier.com/ethicalguidelines.

Authors complete a Journal Publishing Agreement upon acceptance. 模型摘要

Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright, see https://www.elsevier.com/copyright). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce …

Embargo period of 12 months for subscription articles. 模型摘要

This journal offers authors a choice in publishing their research:Open access• Articles are freely available to both subscribers and the wider public with permitted reuse• An open access publication fee is payable by authors or on their behalf (e.g., by their research funder or institution)Subscription• Articles are made available to subscribers as well as developing countries and patient groups t…

Editorials undergo peer review whether invited or unsolicited. 模型摘要

This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

The journal will not consider manuscripts that have appeared in other journals, in part or in whole, except in special circumstances approved by the Editor-in-Chief. Likewise, updates of previously published studies that add minimal new information to an existing publication will not be considered. Overlap between patient groups described in serial manuscripts must be acknowledged, and references …

For work submitted to a preprint server, it is the corresponding author's responsibility to promptly update the preprint server entry to indicate when a paper has been accepted and is currently in press; the author must add proper citation of the online version to the preprint server entry to point users to the peer-reviewed, accepted version of the article.

A clinical trial is defined as any study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. With regards to the reporting of clinical trials, Ophthalmology's policies are similar to the policies of The New England Journal of Medicine (NEJM), and The Journal of the American Medical Association (JA…